title: Anakinra efficacy in a Caucasian patient with renal AA amyloidosis secondary to cryopyrin-associated periodic syndrome.
authors.forename: Tassadit
authors.initials: T
authors.lastname: Aït-Abdesselam
authors.forename: Thierry
authors.initials: T
authors.lastname: Lequerré
authors.forename: Bruno
authors.initials: B
authors.lastname: Legallicier
authors.forename: Arnaud
authors.initials: A
authors.lastname: François
authors.forename: Xavier
authors.initials: X
authors.lastname: Le Loët
authors.forename: Olivier
authors.initials: O
authors.lastname: Vittecoq
mesh_terms: D000328:Adult; D000686:Amyloidosis / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D056587:Cryopyrin-Associated Periodic Syndromes / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D005260:Female; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000627:therapeutic use*; D007678:Kidney Glomerulus / Q000378:metabolism / Q000473:pathology; D009404:Nephrotic Syndrome / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D012074:Remission Induction; D000685:Serum Amyloid A Protein / Q000378:metabolism*; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents; D053590:Interleukin 1 Receptor Antagonist Protein; D000685:Serum Amyloid A Protein